Correlation Between Portmeirion Group and BioNTech

Can any of the company-specific risk be diversified away by investing in both Portmeirion Group and BioNTech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Portmeirion Group and BioNTech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Portmeirion Group PLC and BioNTech SE, you can compare the effects of market volatilities on Portmeirion Group and BioNTech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Portmeirion Group with a short position of BioNTech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Portmeirion Group and BioNTech.

Diversification Opportunities for Portmeirion Group and BioNTech

0.29

Correlation Coefficient

Portmeirion Group  BioNTech

Modest diversification

The 3 months correlation between Portmeirion and BioNTech is 0.29. Overlapping area represents the amount of risk that can be diversified away by holding Portmeirion Group PLC and BioNTech SE in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioNTech SE and Portmeirion Group is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Portmeirion Group PLC are associated (or correlated) with BioNTech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioNTech SE has no effect on the direction of Portmeirion Group i.e., Portmeirion Group and BioNTech go up and down completely randomly.

Pair Corralation between Portmeirion Group and BioNTech

Assuming the 90 days horizon Portmeirion Group PLC is expected to under-perform the BioNTech. But the pink sheet apears to be less risky and, when comparing its historical volatility, Portmeirion Group PLC is 1.05 times less risky than BioNTech. The pink sheet trades about -0.13 of its potential returns per unit of risk. The BioNTech SE is currently generating about -0.06 of returns per unit of risk over similar time horizon. If you would invest  11,377  in BioNTech SE on December 26, 2024 and sell it today you would lose (1,672) from holding BioNTech SE or give up 14.7% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Portmeirion Group PLC  vs.  BioNTech SE

Portmeirion Group PLC

Risk-Adjusted Performance

Very Weak

Over the last 90 days Portmeirion Group PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's primary indicators remain nearly stable which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

BioNTech SE

Risk-Adjusted Performance

Very Weak

Over the last 90 days BioNTech SE has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Portmeirion Group and BioNTech

The main advantage of trading using opposite Portmeirion Group and BioNTech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Portmeirion Group position performs unexpectedly, BioNTech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioNTech will offset losses from the drop in BioNTech's long position.

The idea behind Portmeirion Group PLC and BioNTech SE pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.